Core diluted earnings per share
Core earnings per share calculated on a diluted basis.
Unit CHF Industry Pharmaceuticals
Records
2
Regions
1
Period
2025–2026
Sources
1
The chart
Over time
Global over time. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.
Every record
All records
2 records · 1 region · 2025–2026
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| [Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant a... | Roche | 23 Jul 2026 | 2 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Core diluted earnings per share. Retrieved from https://statorigin.org/indicators/core-diluted-earnings-per-share